<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pharmaceutical Clinical Trials &#187; Amp</title>
	<atom:link href="http://www.pharmaceuticalclinicaltrials.com/tag/amp/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.pharmaceuticalclinicaltrials.com</link>
	<description></description>
	<lastBuildDate>Tue, 30 Mar 2010 18:33:38 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Infertility Research: What Do We Know?</title>
		<link>http://www.pharmaceuticalclinicaltrials.com/infertility-research-what-do-we-know/</link>
		<comments>http://www.pharmaceuticalclinicaltrials.com/infertility-research-what-do-we-know/#comments</comments>
		<pubDate>Tue, 29 Dec 2009 20:16:52 +0000</pubDate>
		<dc:creator>Pharma Tech</dc:creator>
				<category><![CDATA[Trials]]></category>
		<category><![CDATA[5 Million]]></category>
		<category><![CDATA[6 Million]]></category>
		<category><![CDATA[American Society Of Reproductive Medicine]]></category>
		<category><![CDATA[Amp]]></category>
		<category><![CDATA[Infertility]]></category>
		<category><![CDATA[Infertility Issues]]></category>
		<category><![CDATA[Infertility Research]]></category>
		<category><![CDATA[Infertility Specialist]]></category>
		<category><![CDATA[Know]]></category>
		<category><![CDATA[lifestyle]]></category>
		<category><![CDATA[Male Infertility]]></category>
		<category><![CDATA[Married Couples]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[Miscarriages]]></category>
		<category><![CDATA[Misconceptions]]></category>
		<category><![CDATA[Pregnant]]></category>
		<category><![CDATA[Randy Beckett]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Secondary Infertility]]></category>
		<category><![CDATA[Statistics]]></category>
		<category><![CDATA[Unprotected Sex]]></category>

		<guid isPermaLink="false">http://www.pharmaceuticalclinicaltrials.com/infertility-research-what-do-we-know/</guid>
		<description><![CDATA[Copyright (c) 2009 Randy Beckett
Infertility is a condition in which a couple fails to conceive after attempting unprotected sex for a period of at least one year. Statistics reveal that approximately 6 million women between the ages of 16 &#38; 45 have infertility issues while attempting to get pregnant. Simply, infertility is the inability to [...]]]></description>
			<content:encoded><![CDATA[<p>Copyright (c) 2009 Randy Beckett</p>
<p>Infertility is a condition in which a couple fails to conceive after attempting unprotected sex for a period of at least one year. Statistics reveal that approximately 6 million women between the ages of 16 &amp; 45 have infertility issues while attempting to get pregnant. Simply, infertility is the inability to conceive whether it is the female, male or both partners. More than 2 million married couples are now experiencing problems with infertility and this figure is likely to rise mainly due to our current face paced, high stressed lifestyle. Statistics also show that more than 5 million women have sought treatment from infertility specialist for help. If you are experiencing infertility it is important for you to understand that you are not alone. Although knowing this may not make you feel better, it should encourage you to know that because infertility is growing so is research and ultimately new forms of treatment.</p>
<p>Infertility can be broadly defined in 3 forms:</p>
<p>1. Primary infertility: Is defined as a woman whom has never been able to conceive.</p>
<p>2. Secondary infertility: Is defined as a woman whom has had a child but is unable to conceive again.</p>
<p>3. Repeated miscarriages: Is defined as a woman whom fails to carry the baby to term and has encountered frequent miscarriages. Although miscarriage isn?t uncommon, experiencing more than two miscarriages consecutively can be related to infertility.</p>
<p>It is important to understand what infertility is and also to understand the misconceptions concerning infertility. Below you will find a number of items related to misconceptions of infertility:</p>
<p>? Women are the only ones who suffer infertility. This isn?t true, according to medical research infertility is almost equally prevalent in men as in women. The American Society of Reproductive Medicine reveals that about 50% of the cases of infertility are related to female issues, while 30% are related to male infertility factors. The remaining percentage is attributed to problems affecting both female and male, or some unexplained factors.</p>
<p>? Infertility is a mental disorder affecting those people who do not want to get pregnant for some reason. Wrong! Infertility is a disorder involving the reproductive system.</p>
<p>? Infertility is quite common in unhealthy men and women. A person or couples health can definitely be a factor involving infertility, however it is not usually one of the key factors. There are many lifestyle factors that can be involved in creating infertility in an individual including: drinking, smoking, poor diet, exposure to chemicals, drugs and sexually transmitted diseases.</p>
<p>Even the healthiest of couples may experience problems in having a baby. Research shows that women are at their premium fertile state when they are between the ages of 20 &amp; 32. After the age of 35 their fertility tends to decline rapidly. However, age is usually only one aspect of a women?s inability to get pregnant. Age is usually related to the decline in hormonal balance, which is needed to be successful with a pregnancy. Hormonal treatments may be beneficial for a woman who is attempting a pregnancy late in life.</p>
<p>Whatever the case may be, infertility remedies are available in may different forms from natural remedies, pharmaceuticals, surgeries and IVF. The majority of infertility cases are treatable once a proper diagnosis has been completed. The important thing is to stay positive and take charge of your own fertility plan. Whatever direction you decide to move in treating your infertility be sure to do it under a doctor?s supervision for your health as well as your unborn child. Take heart in knowing that 85% of those individuals diagnosed with some form of infertility are able to conceive. Best of luck and God Bless!</p>
<div style="margin:5px;padding:5px;border:1px solid #c1c1c1;font-size: 10px;">
<div class="text">
<p>Randy Beckett is an author, speaker and consultant with over 30 years experience in women&#8217;s healthcare.   For additional information on <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="http://www.infertilityconcerns.com/Infertility-research-html- 2">infertility research</a>, visit <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="http://www.infertilityconcerns.com/a"></a><a rel="nofollow" target="_blank" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="http://www.infertilityconcerns.com">http://www.infertilityconcerns.com</a> </p>
</div>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmaceuticalclinicaltrials.com/infertility-research-what-do-we-know/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Drug Regulatory Affairs &#8211; Careers &amp; Prospects &#8211; Pharmaceutical Industry</title>
		<link>http://www.pharmaceuticalclinicaltrials.com/drug-regulatory-affairs-careers-prospects-pharmaceutical-industry-41/</link>
		<comments>http://www.pharmaceuticalclinicaltrials.com/drug-regulatory-affairs-careers-prospects-pharmaceutical-industry-41/#comments</comments>
		<pubDate>Mon, 21 Dec 2009 20:12:19 +0000</pubDate>
		<dc:creator>Pharma Tech</dc:creator>
				<category><![CDATA[Trials]]></category>
		<category><![CDATA[10 Years]]></category>
		<category><![CDATA[Affairs]]></category>
		<category><![CDATA[Amp]]></category>
		<category><![CDATA[Cagr]]></category>
		<category><![CDATA[Careers]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Health Care Products]]></category>
		<category><![CDATA[Health Products]]></category>
		<category><![CDATA[Heart]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indian Pharmaceutical Industry]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[Legislation]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Prime Responsibilities]]></category>
		<category><![CDATA[Profession]]></category>
		<category><![CDATA[Prospects]]></category>
		<category><![CDATA[Ra]]></category>
		<category><![CDATA[Registration Documents]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Regulatory Affairs]]></category>
		<category><![CDATA[Regulatory Agencies]]></category>
		<category><![CDATA[Selling Drugs]]></category>
		<category><![CDATA[Time And Money]]></category>

		<guid isPermaLink="false">http://www.pharmaceuticalclinicaltrials.com/drug-regulatory-affairs-careers-prospects-pharmaceutical-industry-41/</guid>
		<description><![CDATA[
 
 What is Regulatory Affairs???? :- 
Regulatory Affairs (RA) is an upcoming profession within the biomedical / health products sector. RA profession at its heart is all about Collecting, Analyzing and Communicating the Risks and Benefits of health care products to regulatory agencies and public all over the world.
In an organization their prime responsibilities involves [...]]]></description>
			<content:encoded><![CDATA[</p>
<p> </p>
<p> <strong>What is Regulatory Affairs???? :- </strong>
<p>Regulatory Affairs (RA) is an upcoming profession within the biomedical / health products sector. RA profession at its heart is all about Collecting, Analyzing and Communicating the Risks and Benefits of health care products to regulatory agencies and public all over the world.</p>
<p>In an organization their prime responsibilities involves preparation and presentation of registration documents to regulatory agencies and carry out all following discussion to obtain and maintain marketing authorization (MA) for the products concerned.</p>
<p>They need to keep a track on ever changing legislation in all countries where the companies is looking to market their product.</p>
<p>RA profession is broader than registration of products, they advise companies both strategically and technically at the highest level. Their role begins right from development of a product to making, marketing and post marketing. Their advice at all stages both in terms of legal and technical requirements and restrains help companies save a lot of time and money in developing the product and marketing the same.</p>
<p>They have a major contribution in company’s success both Commercially and Scientifically.</p>
<p><strong>Careers in Regulatory Affairs:- </strong></p>
<p>Pharma is a highly regulated industry the world over and professionals, who can manage regulatory affairs, are in high demand.</p>
<p>Selling drugs is not like selling anything else, when we sell drugs we need to be confident that</p>
<p> They do what they claim to do  They have been through a tough testing process to get from the lab to the market  The side effects are well documented
<p> </p>
<p>This is where regulatory affairs come in.</p>
<p><strong>“Regulatory Affairs Professional is the key link to distributing your drugs to world region.”</strong></p>
<p>The Indian Pharmaceutical industry is one of the fastest growing industry in India, with a CAGR of over 13 % in last 5 years and it is expected to grow at a higher rate in coming 10 years. It is valued at $ 8.0 billion approximately and ranks 4th in terms of volume and 13th in terms of value globally.</p>
<p>With such a high growth rate and rapid globalization there is a substantial need for highly trained professionals ready to perform the work required within this specialized industrial sector who will keep updates with regulatory law, policies and procedures for one or more product lines as well as maintain an understanding of the scientific and technical background of new products.</p>
<p>The increasing graph of the global companies’ setup in India demands the trained and skilled professional on a <strong>Handsome Salary</strong>, looking back for past few years rise in salary is multiplying.</p>
<p>There is a widening gap of rising demand and too few skilled human resource, this has seen a 50 % zoom on average in salaries for skilled manpower specifically in CRO sector alone.  On an average there has been over 30% rises in salaries in Pharmaceutical Sector.</p>
<p>Research &amp; Development activity in the Pharma sector is seeing a rapid growth and this growth is only poised to increase the need for skilled manpower and higher pay scale to retain the skilled.</p>
<p><strong>What you will need to become a RA professional :- </strong></p>
<p> A good background knowledge of the pharmaceuticals and medical environment  A meticulous approach to work  Attention to detail.  Academic Qualification in Regulatory Affairs
<p>You can expect to work in a multidisciplinary workplace where scientists and medics will come from very different backgrounds. Excellent written and verbal communication skills are a must as is the ability to work effectively under pressure.</p>
<p><strong>Global Institute of Regulatory Affairs (GIRA)</strong></p>
<p>GIRA has developed a Post Graduate Diploma (Sunday batches) and Advanced P.G. Diploma in RA (Full Time) which will surely help the professionals as the program address regulatory Affairs within each category of regulatory agencies of various country, Drugs and Medical devices.</p>
<p>This Program will be a complement to those who carrying Science, Pharmacy and Health related degrees, there are many rewarding career opportunities with regulatory affairs for individuals with a variety of backgrounds.</p>
<p>The courses has been developed, under the guidance of Industry and Government Experts, to provide broad regulatory foundations, exposure to the practical, real-world applications of the regulations, and an appreciation of the important roles that regulatory affairs professionals play in the bioscience industry.</p>
<p>Courses are taught by experienced regulatory professionals currently working in device, diagnostic, pharmaceutical and biologic sectors. Instructors bring the regulations to life and infuse their courses with relevant examples and hands-on exercises designed to prepare students for rewarding careers in regulatory affairs.</p>
<p>GIRA is a Division of “Perfect Pharmaceutical Consultants Pvt Ltd” – providing intelligent regulatory solutions since last 20 years</p>
<p>Please contact GIRA for  “FREE Counseling &amp; Course Prospectus”</p>
<p>To know more on RA and its Career visit White Paper section on</p>
<p>Global Institute of Regulatory Affairs</p>
<p><a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="http://www.regulatoryinstitute.com/">www.regulatoryinstitute.com</a></p>
<p> </p>
<p> </p>
<div style="margin:5px;padding:5px;border:1px solid #c1c1c1;font-size: 10px;">
<div class="text">
<p>
Sumit Gupta</p>
<p>Global Institute of Regulatory Affairs &#8211; <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="http://www.regulatoryinstitute.com" target="_blank">www.regulatoryinstitute.com</a></p>
<p>Email ? <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="mailto:info@regulatoryinstitute.com">info@regulatoryinstitute.com</a> / <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="mailto:girapune@gmail.com">girapune@gmail.com</a></p>
</div>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmaceuticalclinicaltrials.com/drug-regulatory-affairs-careers-prospects-pharmaceutical-industry-41/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmaceutical Competitive Intelligence Expanding the Role and Reach of CI</title>
		<link>http://www.pharmaceuticalclinicaltrials.com/pharmaceutical-competitive-intelligence-expanding-the-role-and-reach-of-ci/</link>
		<comments>http://www.pharmaceuticalclinicaltrials.com/pharmaceutical-competitive-intelligence-expanding-the-role-and-reach-of-ci/#comments</comments>
		<pubDate>Wed, 16 Dec 2009 20:08:53 +0000</pubDate>
		<dc:creator>Pharma Tech</dc:creator>
				<category><![CDATA[Trials]]></category>
		<category><![CDATA[Amp]]></category>
		<category><![CDATA[Brand Management]]></category>
		<category><![CDATA[Breeding Grounds]]></category>
		<category><![CDATA[Budgets]]></category>
		<category><![CDATA[Business Development]]></category>
		<category><![CDATA[Business Growth]]></category>
		<category><![CDATA[Career Paths]]></category>
		<category><![CDATA[Competitive]]></category>
		<category><![CDATA[Competitive Intelligence]]></category>
		<category><![CDATA[Cultures]]></category>
		<category><![CDATA[Efficiency]]></category>
		<category><![CDATA[Expanding]]></category>
		<category><![CDATA[Global Level]]></category>
		<category><![CDATA[Growth Opportunities]]></category>
		<category><![CDATA[Intelligence]]></category>
		<category><![CDATA[Internal Clients]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Phase By Phase]]></category>
		<category><![CDATA[Placements]]></category>
		<category><![CDATA[Presence]]></category>
		<category><![CDATA[Reach]]></category>
		<category><![CDATA[Role]]></category>
		<category><![CDATA[Rt]]></category>
		<category><![CDATA[Signs]]></category>
		<category><![CDATA[Successes]]></category>
		<category><![CDATA[Upswing]]></category>

		<guid isPermaLink="false">http://www.pharmaceuticalclinicaltrials.com/pharmaceutical-competitive-intelligence-expanding-the-role-and-reach-of-ci/</guid>
		<description><![CDATA[Solidify competitive intelligence’s presence to optimize decision makingPharmaceutical competitive intelligence (CI) helps drive decision-making processes across an organization. As a forward-thinking, proactive support function, CI influences business development and brand management, among other areas. CI identifies market risks as well as business growth opportunities. ( http://www.bharatbook.com/detail.asp?id=77309&#38;rt=Pharmaceutical-Competitive-Intelligence-Expanding-the-Role-and-Reach-of-CI-PH110.html )
Recent years have seen CI groups on the upswing. [...]]]></description>
			<content:encoded><![CDATA[<p>Solidify competitive intelligence’s presence to optimize decision making<br />Pharmaceutical competitive intelligence (CI) helps drive decision-making processes across an organization. As a forward-thinking, proactive support function, CI influences business development and brand management, among other areas. CI identifies market risks as well as business growth opportunities. ( http://www.bharatbook.com/detail.asp?id=77309&amp;rt=Pharmaceutical-Competitive-Intelligence-Expanding-the-Role-and-Reach-of-CI-PH110.html )</p>
<p>Recent years have seen CI groups on the upswing. Their role is evolving and developing a greater emphasis on adding strategic value. At the same time, CI’s budgets and staffing are increasing. Recent trends in structuring have led to increased efficiency. These are certainly encouraging signs, and CI groups are adapting to the changes.But there is still much work to be done. CI teams still must fight for resources to succeed. They must also demonstrate their value and trumpet their successes. To not only survive, but to thrive as a function, CI must attract top talent, increase its reach and create a CI culture within an organization.Pharmaceutical Competitive Intelligence examines top companies’ practices to provide a guide for improving CI efforts. This report presents the focal points of the research in three chapters:</p>
<p>* Structuring for Success – Provides details on CI structures, including global-level reporting lines and placements; ways in which CI team trumpet their successes and create CI cultures; and the career paths laid out to make CI teams breeding grounds for future pharma leaders<br />* Resourcing for Growth – Reveals CI department-level budgets and staffing; brand-level phase-by-phase spending and staffing, which groups fund CI; and how companies demonstrate ROI on CI<br />* Increasing CI’s Reach – Examines how companies communicate their strategic value to internal clients and the resources and tools for collecting CI<br /> </p>
<p>To know more and to buy a copy of your report feel free to visit : <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="http://www.bharatbook.com/detail.asp?id=77309&amp;rt=Pharmaceutical-Competitive-Intelligence-Expanding-the-Role-and-Reach-of-CI-PH110.html">http://www.bharatbook.com/detail.asp?id=77309&amp;rt=Pharmaceutical-Competitive-Intelligence-Expanding-the-Role-and-Reach-of-CI-PH110.html</a> </p>
<p>Or</p>
<p>Contact us at :</p>
<p>Bharat Book Bureau<br />Tel: +91 22 27578668<br />Fax: +91 22 27579131<br />Email: <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="mailto:info@bharatbook.com">info@bharatbook.com</a> <br />Website: <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="http://www.bharatbook.com/">www.bharatbook.com</a> <br />Blog: http://bharatbookresearch.blogspot.com <br />Follow us on twitter: http://twitter.com/3bbharatbook</p>
<div style="margin:5px;padding:5px;border:1px solid #c1c1c1;font-size: 10px;">
<div class="text">
<p>We are the leading information aggregator, facilitates and supports the business information needs. With over 115,000 reports, you can get instant access and insights on the studies in yo for market research , corporate / strategic planning by providing the latest information in the form of reports, journals, magazines and databases on varied industries like automotive, oil and gas, shipping, textiles, pharmaceuticals, energy, banking, finance, insurance, risk management, country intelligence, consumer &amp; durable goods, chemical and  more ur areas of interest. Contact us at +91 22 27578668 / 27579438 or email <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="mailto:info@bharatbook.com">info@bharatbook.com</a> or our website <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="http://www.bharatbook.com" target="_blank">www.bharatbook.com</a></p>
</div>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmaceuticalclinicaltrials.com/pharmaceutical-competitive-intelligence-expanding-the-role-and-reach-of-ci/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drug Regulatory Affairs &#8211; Careers &amp; Prospects &#8211; Pharmaceutical Industry</title>
		<link>http://www.pharmaceuticalclinicaltrials.com/drug-regulatory-affairs-careers-prospects-pharmaceutical-industry-40/</link>
		<comments>http://www.pharmaceuticalclinicaltrials.com/drug-regulatory-affairs-careers-prospects-pharmaceutical-industry-40/#comments</comments>
		<pubDate>Tue, 15 Dec 2009 20:08:56 +0000</pubDate>
		<dc:creator>Pharma Tech</dc:creator>
				<category><![CDATA[Trials]]></category>
		<category><![CDATA[10 Years]]></category>
		<category><![CDATA[Affairs]]></category>
		<category><![CDATA[Amp]]></category>
		<category><![CDATA[Cagr]]></category>
		<category><![CDATA[Careers]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Health Care Products]]></category>
		<category><![CDATA[Health Products]]></category>
		<category><![CDATA[Heart]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indian Pharmaceutical Industry]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[Legislation]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Prime Responsibilities]]></category>
		<category><![CDATA[Profession]]></category>
		<category><![CDATA[Prospects]]></category>
		<category><![CDATA[Ra]]></category>
		<category><![CDATA[Registration Documents]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Regulatory Affairs]]></category>
		<category><![CDATA[Regulatory Agencies]]></category>
		<category><![CDATA[Selling Drugs]]></category>
		<category><![CDATA[Time And Money]]></category>

		<guid isPermaLink="false">http://www.pharmaceuticalclinicaltrials.com/drug-regulatory-affairs-careers-prospects-pharmaceutical-industry-40/</guid>
		<description><![CDATA[
 
 What is Regulatory Affairs???? :- 
Regulatory Affairs (RA) is an upcoming profession within the biomedical / health products sector. RA profession at its heart is all about Collecting, Analyzing and Communicating the Risks and Benefits of health care products to regulatory agencies and public all over the world.
In an organization their prime responsibilities involves [...]]]></description>
			<content:encoded><![CDATA[</p>
<p> </p>
<p> <strong>What is Regulatory Affairs???? :- </strong>
<p>Regulatory Affairs (RA) is an upcoming profession within the biomedical / health products sector. RA profession at its heart is all about Collecting, Analyzing and Communicating the Risks and Benefits of health care products to regulatory agencies and public all over the world.</p>
<p>In an organization their prime responsibilities involves preparation and presentation of registration documents to regulatory agencies and carry out all following discussion to obtain and maintain marketing authorization (MA) for the products concerned.</p>
<p>They need to keep a track on ever changing legislation in all countries where the companies is looking to market their product.</p>
<p>RA profession is broader than registration of products, they advise companies both strategically and technically at the highest level. Their role begins right from development of a product to making, marketing and post marketing. Their advice at all stages both in terms of legal and technical requirements and restrains help companies save a lot of time and money in developing the product and marketing the same.</p>
<p>They have a major contribution in company’s success both Commercially and Scientifically.</p>
<p><strong>Careers in Regulatory Affairs:- </strong></p>
<p>Pharma is a highly regulated industry the world over and professionals, who can manage regulatory affairs, are in high demand.</p>
<p>Selling drugs is not like selling anything else, when we sell drugs we need to be confident that</p>
<p> They do what they claim to do  They have been through a tough testing process to get from the lab to the market  The side effects are well documented
<p> </p>
<p>This is where regulatory affairs come in.</p>
<p><strong>“Regulatory Affairs Professional is the key link to distributing your drugs to world region.”</strong></p>
<p>The Indian Pharmaceutical industry is one of the fastest growing industry in India, with a CAGR of over 13 % in last 5 years and it is expected to grow at a higher rate in coming 10 years. It is valued at $ 8.0 billion approximately and ranks 4th in terms of volume and 13th in terms of value globally.</p>
<p>With such a high growth rate and rapid globalization there is a substantial need for highly trained professionals ready to perform the work required within this specialized industrial sector who will keep updates with regulatory law, policies and procedures for one or more product lines as well as maintain an understanding of the scientific and technical background of new products.</p>
<p>The increasing graph of the global companies’ setup in India demands the trained and skilled professional on a <strong>Handsome Salary</strong>, looking back for past few years rise in salary is multiplying.</p>
<p>There is a widening gap of rising demand and too few skilled human resource, this has seen a 50 % zoom on average in salaries for skilled manpower specifically in CRO sector alone.  On an average there has been over 30% rises in salaries in Pharmaceutical Sector.</p>
<p>Research &amp; Development activity in the Pharma sector is seeing a rapid growth and this growth is only poised to increase the need for skilled manpower and higher pay scale to retain the skilled.</p>
<p><strong>What you will need to become a RA professional :- </strong></p>
<p> A good background knowledge of the pharmaceuticals and medical environment  A meticulous approach to work  Attention to detail.  Academic Qualification in Regulatory Affairs
<p>You can expect to work in a multidisciplinary workplace where scientists and medics will come from very different backgrounds. Excellent written and verbal communication skills are a must as is the ability to work effectively under pressure.</p>
<p><strong>Global Institute of Regulatory Affairs (GIRA)</strong></p>
<p>GIRA has developed a Post Graduate Diploma (Sunday batches) and Advanced P.G. Diploma in RA (Full Time) which will surely help the professionals as the program address regulatory Affairs within each category of regulatory agencies of various country, Drugs and Medical devices.</p>
<p>This Program will be a complement to those who carrying Science, Pharmacy and Health related degrees, there are many rewarding career opportunities with regulatory affairs for individuals with a variety of backgrounds.</p>
<p>The courses has been developed, under the guidance of Industry and Government Experts, to provide broad regulatory foundations, exposure to the practical, real-world applications of the regulations, and an appreciation of the important roles that regulatory affairs professionals play in the bioscience industry.</p>
<p>Courses are taught by experienced regulatory professionals currently working in device, diagnostic, pharmaceutical and biologic sectors. Instructors bring the regulations to life and infuse their courses with relevant examples and hands-on exercises designed to prepare students for rewarding careers in regulatory affairs.</p>
<p>GIRA is a Division of “Perfect Pharmaceutical Consultants Pvt Ltd” – providing intelligent regulatory solutions since last 20 years</p>
<p>Please contact GIRA for  “FREE Counseling &amp; Course Prospectus”</p>
<p>To know more on RA and its Career visit White Paper section on</p>
<p>Global Institute of Regulatory Affairs</p>
<p><a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="http://www.regulatoryinstitute.com/">www.regulatoryinstitute.com</a></p>
<p> </p>
<p> </p>
<div style="margin:5px;padding:5px;border:1px solid #c1c1c1;font-size: 10px;">
<div class="text">
<p>
Sumit Gupta</p>
<p>Global Institute of Regulatory Affairs &#8211; <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="http://www.regulatoryinstitute.com" target="_blank">www.regulatoryinstitute.com</a></p>
<p>Email ? <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="mailto:info@regulatoryinstitute.com">info@regulatoryinstitute.com</a> / <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="mailto:girapune@gmail.com">girapune@gmail.com</a></p>
</div>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmaceuticalclinicaltrials.com/drug-regulatory-affairs-careers-prospects-pharmaceutical-industry-40/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drug Regulatory Affairs &#8211; Careers &amp; Prospects &#8211; Pharmaceutical Industry</title>
		<link>http://www.pharmaceuticalclinicaltrials.com/drug-regulatory-affairs-careers-prospects-pharmaceutical-industry-39/</link>
		<comments>http://www.pharmaceuticalclinicaltrials.com/drug-regulatory-affairs-careers-prospects-pharmaceutical-industry-39/#comments</comments>
		<pubDate>Mon, 14 Dec 2009 20:08:10 +0000</pubDate>
		<dc:creator>Pharma Tech</dc:creator>
				<category><![CDATA[Trials]]></category>
		<category><![CDATA[10 Years]]></category>
		<category><![CDATA[Affairs]]></category>
		<category><![CDATA[Amp]]></category>
		<category><![CDATA[Cagr]]></category>
		<category><![CDATA[Careers]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Health Care Products]]></category>
		<category><![CDATA[Health Products]]></category>
		<category><![CDATA[Heart]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indian Pharmaceutical Industry]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[Legislation]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Prime Responsibilities]]></category>
		<category><![CDATA[Profession]]></category>
		<category><![CDATA[Prospects]]></category>
		<category><![CDATA[Ra]]></category>
		<category><![CDATA[Registration Documents]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Regulatory Affairs]]></category>
		<category><![CDATA[Regulatory Agencies]]></category>
		<category><![CDATA[Selling Drugs]]></category>
		<category><![CDATA[Time And Money]]></category>

		<guid isPermaLink="false">http://www.pharmaceuticalclinicaltrials.com/drug-regulatory-affairs-careers-prospects-pharmaceutical-industry-39/</guid>
		<description><![CDATA[
 
 What is Regulatory Affairs???? :- 
Regulatory Affairs (RA) is an upcoming profession within the biomedical / health products sector. RA profession at its heart is all about Collecting, Analyzing and Communicating the Risks and Benefits of health care products to regulatory agencies and public all over the world.
In an organization their prime responsibilities involves [...]]]></description>
			<content:encoded><![CDATA[</p>
<p> </p>
<p> <strong>What is Regulatory Affairs???? :- </strong>
<p>Regulatory Affairs (RA) is an upcoming profession within the biomedical / health products sector. RA profession at its heart is all about Collecting, Analyzing and Communicating the Risks and Benefits of health care products to regulatory agencies and public all over the world.</p>
<p>In an organization their prime responsibilities involves preparation and presentation of registration documents to regulatory agencies and carry out all following discussion to obtain and maintain marketing authorization (MA) for the products concerned.</p>
<p>They need to keep a track on ever changing legislation in all countries where the companies is looking to market their product.</p>
<p>RA profession is broader than registration of products, they advise companies both strategically and technically at the highest level. Their role begins right from development of a product to making, marketing and post marketing. Their advice at all stages both in terms of legal and technical requirements and restrains help companies save a lot of time and money in developing the product and marketing the same.</p>
<p>They have a major contribution in company’s success both Commercially and Scientifically.</p>
<p><strong>Careers in Regulatory Affairs:- </strong></p>
<p>Pharma is a highly regulated industry the world over and professionals, who can manage regulatory affairs, are in high demand.</p>
<p>Selling drugs is not like selling anything else, when we sell drugs we need to be confident that</p>
<p> They do what they claim to do  They have been through a tough testing process to get from the lab to the market  The side effects are well documented
<p> </p>
<p>This is where regulatory affairs come in.</p>
<p><strong>“Regulatory Affairs Professional is the key link to distributing your drugs to world region.”</strong></p>
<p>The Indian Pharmaceutical industry is one of the fastest growing industry in India, with a CAGR of over 13 % in last 5 years and it is expected to grow at a higher rate in coming 10 years. It is valued at $ 8.0 billion approximately and ranks 4th in terms of volume and 13th in terms of value globally.</p>
<p>With such a high growth rate and rapid globalization there is a substantial need for highly trained professionals ready to perform the work required within this specialized industrial sector who will keep updates with regulatory law, policies and procedures for one or more product lines as well as maintain an understanding of the scientific and technical background of new products.</p>
<p>The increasing graph of the global companies’ setup in India demands the trained and skilled professional on a <strong>Handsome Salary</strong>, looking back for past few years rise in salary is multiplying.</p>
<p>There is a widening gap of rising demand and too few skilled human resource, this has seen a 50 % zoom on average in salaries for skilled manpower specifically in CRO sector alone.  On an average there has been over 30% rises in salaries in Pharmaceutical Sector.</p>
<p>Research &amp; Development activity in the Pharma sector is seeing a rapid growth and this growth is only poised to increase the need for skilled manpower and higher pay scale to retain the skilled.</p>
<p><strong>What you will need to become a RA professional :- </strong></p>
<p> A good background knowledge of the pharmaceuticals and medical environment  A meticulous approach to work  Attention to detail.  Academic Qualification in Regulatory Affairs
<p>You can expect to work in a multidisciplinary workplace where scientists and medics will come from very different backgrounds. Excellent written and verbal communication skills are a must as is the ability to work effectively under pressure.</p>
<p><strong>Global Institute of Regulatory Affairs (GIRA)</strong></p>
<p>GIRA has developed a Post Graduate Diploma (Sunday batches) and Advanced P.G. Diploma in RA (Full Time) which will surely help the professionals as the program address regulatory Affairs within each category of regulatory agencies of various country, Drugs and Medical devices.</p>
<p>This Program will be a complement to those who carrying Science, Pharmacy and Health related degrees, there are many rewarding career opportunities with regulatory affairs for individuals with a variety of backgrounds.</p>
<p>The courses has been developed, under the guidance of Industry and Government Experts, to provide broad regulatory foundations, exposure to the practical, real-world applications of the regulations, and an appreciation of the important roles that regulatory affairs professionals play in the bioscience industry.</p>
<p>Courses are taught by experienced regulatory professionals currently working in device, diagnostic, pharmaceutical and biologic sectors. Instructors bring the regulations to life and infuse their courses with relevant examples and hands-on exercises designed to prepare students for rewarding careers in regulatory affairs.</p>
<p>GIRA is a Division of “Perfect Pharmaceutical Consultants Pvt Ltd” – providing intelligent regulatory solutions since last 20 years</p>
<p>Please contact GIRA for  “FREE Counseling &amp; Course Prospectus”</p>
<p>To know more on RA and its Career visit White Paper section on</p>
<p>Global Institute of Regulatory Affairs</p>
<p><a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="http://www.regulatoryinstitute.com/">www.regulatoryinstitute.com</a></p>
<p> </p>
<p> </p>
<div style="margin:5px;padding:5px;border:1px solid #c1c1c1;font-size: 10px;">
<div class="text">
<p>
Sumit Gupta</p>
<p>Global Institute of Regulatory Affairs &#8211; <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="http://www.regulatoryinstitute.com" target="_blank">www.regulatoryinstitute.com</a></p>
<p>Email ? <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="mailto:info@regulatoryinstitute.com">info@regulatoryinstitute.com</a> / <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="mailto:girapune@gmail.com">girapune@gmail.com</a></p>
</div>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmaceuticalclinicaltrials.com/drug-regulatory-affairs-careers-prospects-pharmaceutical-industry-39/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PhRMA code tightens limits on gift giving. : An article from: Skin &amp; Allergy News</title>
		<link>http://www.pharmaceuticalclinicaltrials.com/phrma-code-tightens-limits-on-gift-giving-an-article-from-skin-allergy-news-10/</link>
		<comments>http://www.pharmaceuticalclinicaltrials.com/phrma-code-tightens-limits-on-gift-giving-an-article-from-skin-allergy-news-10/#comments</comments>
		<pubDate>Fri, 11 Dec 2009 04:18:01 +0000</pubDate>
		<dc:creator>Pharma Tech</dc:creator>
				<category><![CDATA[Trials]]></category>
		<category><![CDATA[Allergy]]></category>
		<category><![CDATA[Allergy News]]></category>
		<category><![CDATA[Allergy Product]]></category>
		<category><![CDATA[Amazon]]></category>
		<category><![CDATA[Amp]]></category>
		<category><![CDATA[article]]></category>
		<category><![CDATA[August 1]]></category>
		<category><![CDATA[Citation Details]]></category>
		<category><![CDATA[code]]></category>
		<category><![CDATA[Diana]]></category>
		<category><![CDATA[Digital Document]]></category>
		<category><![CDATA[From]]></category>
		<category><![CDATA[gift]]></category>
		<category><![CDATA[giving.]]></category>
		<category><![CDATA[Group Volume]]></category>
		<category><![CDATA[International Medical News Group]]></category>
		<category><![CDATA[limits]]></category>
		<category><![CDATA[Medical Groups]]></category>
		<category><![CDATA[Medical News Group]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[News Magazine]]></category>
		<category><![CDATA[Pharmaceutical Research]]></category>
		<category><![CDATA[PhRMA]]></category>
		<category><![CDATA[Phrma Code]]></category>
		<category><![CDATA[Product Description]]></category>
		<category><![CDATA[Publisher]]></category>
		<category><![CDATA[Skin]]></category>
		<category><![CDATA[Skin Allergy]]></category>
		<category><![CDATA[Thomson Gale]]></category>
		<category><![CDATA[tightens]]></category>
		<category><![CDATA[Web Browser]]></category>

		<guid isPermaLink="false">http://www.pharmaceuticalclinicaltrials.com/phrma-code-tightens-limits-on-gift-giving-an-article-from-skin-allergy-news-10/</guid>
		<description><![CDATA[
Product DescriptionThis digital document is an article from Skin &#038; Allergy News, published by International Medical News Group on August 1, 2002. The length of the article is 657 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.pharmaceuticalclinicaltrials.com/go/link/4117/1" rel="nofollow"><img style="float:left;margin: 0 20px 10px 0;" src="" /></a><br />
<b>Product Description</b><br />This digital document is an article from Skin &#038; Allergy News, published by International Medical News Group on August 1, 2002. The length of the article is 657 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.<BR><BR><strong>Citation Details</strong><br /><strong>Title:</strong> PhRMA code tightens limits on gift giving. (Hailed by consumer, Medical Groups).(Pharmaceutical Research and Manufacturers of America)<br /><strong>Author:</strong> Diana Mahoney<br /><strong>Publication:</strong> <em>Skin &#038; Allergy News</em> (Magazine/Journal)<br /><strong>Date:</strong> August 1, 2002<br /><strong>Publisher:</strong> International Medical News Group<br /><strong>Volume:</strong> 33  <strong>Issue:</strong> 8  <strong>Page:</strong> 46(1)<BR><BR>Distributed by Thomson Gale<br />
<a href="http://www.pharmaceuticalclinicaltrials.com/go/PhRMA_code_tightens_limits_on_gift_giving_An_article_from_Skin_Allergy_News/4117/2" title="PhRMA code tightens limits on gift giving. : An article from: Skin &#038; Allergy News" rel="nofollow"><b>PhRMA code tightens limits on gift giving. : An article from: Skin &#038; Allergy News</b></a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmaceuticalclinicaltrials.com/phrma-code-tightens-limits-on-gift-giving-an-article-from-skin-allergy-news-10/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PhRMA code tightens limits on gift giving. : An article from: Skin &amp; Allergy News</title>
		<link>http://www.pharmaceuticalclinicaltrials.com/phrma-code-tightens-limits-on-gift-giving-an-article-from-skin-allergy-news-9/</link>
		<comments>http://www.pharmaceuticalclinicaltrials.com/phrma-code-tightens-limits-on-gift-giving-an-article-from-skin-allergy-news-9/#comments</comments>
		<pubDate>Thu, 10 Dec 2009 12:09:36 +0000</pubDate>
		<dc:creator>Pharma Tech</dc:creator>
				<category><![CDATA[Trials]]></category>
		<category><![CDATA[Allergy]]></category>
		<category><![CDATA[Allergy News]]></category>
		<category><![CDATA[Allergy Product]]></category>
		<category><![CDATA[Amazon]]></category>
		<category><![CDATA[Amp]]></category>
		<category><![CDATA[article]]></category>
		<category><![CDATA[August 1]]></category>
		<category><![CDATA[Citation Details]]></category>
		<category><![CDATA[code]]></category>
		<category><![CDATA[Diana]]></category>
		<category><![CDATA[Digital Document]]></category>
		<category><![CDATA[From]]></category>
		<category><![CDATA[gift]]></category>
		<category><![CDATA[giving.]]></category>
		<category><![CDATA[Group Volume]]></category>
		<category><![CDATA[International Medical News Group]]></category>
		<category><![CDATA[limits]]></category>
		<category><![CDATA[Medical Groups]]></category>
		<category><![CDATA[Medical News Group]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[News Magazine]]></category>
		<category><![CDATA[Pharmaceutical Research]]></category>
		<category><![CDATA[PhRMA]]></category>
		<category><![CDATA[Phrma Code]]></category>
		<category><![CDATA[Product Description]]></category>
		<category><![CDATA[Publisher]]></category>
		<category><![CDATA[Skin]]></category>
		<category><![CDATA[Skin Allergy]]></category>
		<category><![CDATA[Thomson Gale]]></category>
		<category><![CDATA[tightens]]></category>
		<category><![CDATA[Web Browser]]></category>

		<guid isPermaLink="false">http://www.pharmaceuticalclinicaltrials.com/phrma-code-tightens-limits-on-gift-giving-an-article-from-skin-allergy-news-9/</guid>
		<description><![CDATA[
Product DescriptionThis digital document is an article from Skin &#038; Allergy News, published by International Medical News Group on August 1, 2002. The length of the article is 657 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.pharmaceuticalclinicaltrials.com/go/link/4112/1" rel="nofollow"><img style="float:left;margin: 0 20px 10px 0;" src="" /></a><br />
<b>Product Description</b><br />This digital document is an article from Skin &#038; Allergy News, published by International Medical News Group on August 1, 2002. The length of the article is 657 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.<BR><BR><strong>Citation Details</strong><br /><strong>Title:</strong> PhRMA code tightens limits on gift giving. (Hailed by consumer, Medical Groups).(Pharmaceutical Research and Manufacturers of America)<br /><strong>Author:</strong> Diana Mahoney<br /><strong>Publication:</strong> <em>Skin &#038; Allergy News</em> (Magazine/Journal)<br /><strong>Date:</strong> August 1, 2002<br /><strong>Publisher:</strong> International Medical News Group<br /><strong>Volume:</strong> 33  <strong>Issue:</strong> 8  <strong>Page:</strong> 46(1)<BR><BR>Distributed by Thomson Gale<br />
<a href="http://www.pharmaceuticalclinicaltrials.com/go/PhRMA_code_tightens_limits_on_gift_giving_An_article_from_Skin_Allergy_News/4112/2" title="PhRMA code tightens limits on gift giving. : An article from: Skin &#038; Allergy News" rel="nofollow"><b>PhRMA code tightens limits on gift giving. : An article from: Skin &#038; Allergy News</b></a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmaceuticalclinicaltrials.com/phrma-code-tightens-limits-on-gift-giving-an-article-from-skin-allergy-news-9/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Do Accounting Rules Discourage Research &amp; Development?</title>
		<link>http://www.pharmaceuticalclinicaltrials.com/do-accounting-rules-discourage-research-development-12/</link>
		<comments>http://www.pharmaceuticalclinicaltrials.com/do-accounting-rules-discourage-research-development-12/#comments</comments>
		<pubDate>Wed, 09 Dec 2009 04:07:55 +0000</pubDate>
		<dc:creator>Pharma Tech</dc:creator>
				<category><![CDATA[Trials]]></category>
		<category><![CDATA[1 Billion]]></category>
		<category><![CDATA[Accounting]]></category>
		<category><![CDATA[Accounting Research]]></category>
		<category><![CDATA[Accounting Rules]]></category>
		<category><![CDATA[Amp]]></category>
		<category><![CDATA[Billions Of Dollars]]></category>
		<category><![CDATA[Depreciation Expense]]></category>
		<category><![CDATA[Development]]></category>
		<category><![CDATA[Development Businesses]]></category>
		<category><![CDATA[Discourage]]></category>
		<category><![CDATA[Economic Benefit]]></category>
		<category><![CDATA[Expenditures]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Fda Approval]]></category>
		<category><![CDATA[Male Enhancement Pill]]></category>
		<category><![CDATA[Market Research]]></category>
		<category><![CDATA[Outlay]]></category>
		<category><![CDATA[Outlays]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Periods]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Research And Development]]></category>
		<category><![CDATA[Rules]]></category>
		<category><![CDATA[Tangible Assets]]></category>

		<guid isPermaLink="false">http://www.pharmaceuticalclinicaltrials.com/do-accounting-rules-discourage-research-development-12/</guid>
		<description><![CDATA[Businesses spend billions of dollars trying to develop new and better products, These outlays are referred to as research and development (R &#38; D) costs. Accounting rule makers have struggled with how best to classify such expenditures. Should they be treated as expenses or assets? The classification of an outlay as an expense or an [...]]]></description>
			<content:encoded><![CDATA[<p>Businesses spend billions of dollars trying to develop new and better products, These outlays are referred to as research and development (R &amp; D) costs. Accounting rule makers have struggled with how best to classify such expenditures. Should they be treated as expenses or assets? The classification of an outlay as an expense or an asset depends upon how long the firm will benefit from the outlay. If the benefit will be for more than one accounting period, it is classified as an asset. If the outlay provides economic benefit for less than a year it is generally classified as an expense. </p>
<p>&#13;<br />
Tangible assets such as machinery and equipment produce income over several years. These tangible assets usually have easily ascertainable costs, which are spread over the assets&#8217; estimated useful lives in the form of depreciation expense. On the other hand, one month&#8217;s rent payment is an expense because the outlay entitles the firm to only one month of economic benefit. Now consider the following example of an R &amp; D cost.</p>
<p>&#13;<br />
Example. Mizer Pharmaceutical has in the last five years spent $65 million on research and testing of a male enhancement pill that actually works and can garner FDA approval. The five years of research and development outlays has lead to the development of an effective pill that they will market and patent under the trade name Mirakle Grow. Market research indicates that it will generate at least $1 billion in sales annually as long as they hold the exclusive patent.    </p>
<p>&#13;<br />
Since the R &amp; D outlays have lead to the development of a pill that will generate significant revenue over several years you would expect that the outlays would be classified as assets rather than period expenses. Well you would be wrong.  In fact, accounting rules require that R &amp; D costs be treated as expenses rather than assets even though these outlays clearly are intended to benefit future accounting periods. There are two reasons why accounting rules treat R &amp; D outlays as expenses.</p>
<p>&#13;<br />
First it is a cruel fact of life that not all R &amp; D outlays lead to the development of marketable products. In fact, a relatively low percentage of such outlays lead to successful products. For example, it may turn out that the Mirakle Grow drug has adverse side effects that would preclude FDA approval. </p>
<p>&#13;<br />
A second problem in treating R &amp; D costs as assets involves deciding their useful life. Assuming that successful R &amp; D costs can be identified, over what period of time do we spread or amortize these costs? If the R &amp; D costs lead to a patent we could simply use the life of a patent as our guide. But what really matters is the life cycle of a successful new product, not the period of patent enforceability. Who knows how long a period that should be? In the case of Mizer&#8217;s male enhancement pill it is entirely possible that an alternative pill developed by a competitor could provide stiff competition to Mirakle Grow. If this occurs demand for Mirakle Grow might peter out in a much shorter period of time than the life of the patent.</p>
<p>&#13;<br />
If accounting rules allowed the treatment of R &amp; D costs as assets, management would be sorely tempted to record both unsuccessful and successful outlays as assets. This would lead to the overstatement of assets, the understatement of expenses and in turn the overstatement of income. Even if management were neutral and fair minded it is often impossible to predict which R &amp; D costs will lead to successful products and which will not. </p>
<p>&#13;<br />
Unintended Consequences</p>
<p>&#13;<br />
Accounting rule maker&#8217;s decision to not treat R &amp; D costs as assets probably has undesirable consequences for firms and society as a whole. In the current environment in which publicly traded firms are managed there is great pressure on managers to insure that stock prices are maintained. CEO&#8217;s of large corporations are partially compensated and evaluated based upon their firm&#8217;s stock price. In turn, stock prices are greatly affected by the current and near term reported earnings of the company. Under current accounting rules a CEO interested in short-term earnings will avoid long term R &amp; D commitments because they will depress current earnings and hence the stock price. However the long-term prospects of a business may be enhanced significantly by increased expenditures on R &amp; D. So the accounting treatment of R &amp; D probably serves as a disincentive to make such outlays despite the fact that such outlays might be in the long run best interest of the firm. </p>
<p>&#13;<br />
Society is probably also better off if companies increase their R &amp; D outlays. So the current R &amp; D rules may be bad for businesses and bad for society as a whole. The rules may prevent individual firms from overstating income and assets in the short run but reduce the income of the firms and the well being of society in the long run.</p>
<div style="margin:5px;padding:5px;border:1px solid #c1c1c1;font-size: 10px;">
<div class="text">
<p>Michael Sack Elmaleh is a Certified Public Accountant and Certified Valuation Analyst. His book, &#8220;Financial Accounting: A Mercifully Brief Introduction&#8221;, has received wide critical acclaim. He has nearly 30 years of accounting and 10 years of teaching experience.His web site is <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="http://understand-accounting.net"></a>understand-accounting.net </p>
</div>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmaceuticalclinicaltrials.com/do-accounting-rules-discourage-research-development-12/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PhRMA code tightens limits on gift giving. : An article from: Skin &amp; Allergy News</title>
		<link>http://www.pharmaceuticalclinicaltrials.com/phrma-code-tightens-limits-on-gift-giving-an-article-from-skin-allergy-news-8/</link>
		<comments>http://www.pharmaceuticalclinicaltrials.com/phrma-code-tightens-limits-on-gift-giving-an-article-from-skin-allergy-news-8/#comments</comments>
		<pubDate>Mon, 07 Dec 2009 20:09:16 +0000</pubDate>
		<dc:creator>Pharma Tech</dc:creator>
				<category><![CDATA[Trials]]></category>
		<category><![CDATA[Allergy]]></category>
		<category><![CDATA[Allergy News]]></category>
		<category><![CDATA[Allergy Product]]></category>
		<category><![CDATA[Amazon]]></category>
		<category><![CDATA[Amp]]></category>
		<category><![CDATA[article]]></category>
		<category><![CDATA[August 1]]></category>
		<category><![CDATA[Citation Details]]></category>
		<category><![CDATA[code]]></category>
		<category><![CDATA[Diana]]></category>
		<category><![CDATA[Digital Document]]></category>
		<category><![CDATA[From]]></category>
		<category><![CDATA[gift]]></category>
		<category><![CDATA[giving.]]></category>
		<category><![CDATA[Group Volume]]></category>
		<category><![CDATA[International Medical News Group]]></category>
		<category><![CDATA[limits]]></category>
		<category><![CDATA[Medical Groups]]></category>
		<category><![CDATA[Medical News Group]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[News Magazine]]></category>
		<category><![CDATA[Pharmaceutical Research]]></category>
		<category><![CDATA[PhRMA]]></category>
		<category><![CDATA[Phrma Code]]></category>
		<category><![CDATA[Product Description]]></category>
		<category><![CDATA[Publisher]]></category>
		<category><![CDATA[Skin]]></category>
		<category><![CDATA[Skin Allergy]]></category>
		<category><![CDATA[Thomson Gale]]></category>
		<category><![CDATA[tightens]]></category>
		<category><![CDATA[Web Browser]]></category>

		<guid isPermaLink="false">http://www.pharmaceuticalclinicaltrials.com/phrma-code-tightens-limits-on-gift-giving-an-article-from-skin-allergy-news-8/</guid>
		<description><![CDATA[
Product DescriptionThis digital document is an article from Skin &#038; Allergy News, published by International Medical News Group on August 1, 2002. The length of the article is 657 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.pharmaceuticalclinicaltrials.com/go/link/4097/1" rel="nofollow"><img style="float:left;margin: 0 20px 10px 0;" src="" /></a><br />
<b>Product Description</b><br />This digital document is an article from Skin &#038; Allergy News, published by International Medical News Group on August 1, 2002. The length of the article is 657 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.<BR><BR><strong>Citation Details</strong><br /><strong>Title:</strong> PhRMA code tightens limits on gift giving. (Hailed by consumer, Medical Groups).(Pharmaceutical Research and Manufacturers of America)<br /><strong>Author:</strong> Diana Mahoney<br /><strong>Publication:</strong> <em>Skin &#038; Allergy News</em> (Magazine/Journal)<br /><strong>Date:</strong> August 1, 2002<br /><strong>Publisher:</strong> International Medical News Group<br /><strong>Volume:</strong> 33  <strong>Issue:</strong> 8  <strong>Page:</strong> 46(1)<BR><BR>Distributed by Thomson Gale<br />
<a href="http://www.pharmaceuticalclinicaltrials.com/go/PhRMA_code_tightens_limits_on_gift_giving_An_article_from_Skin_Allergy_News/4097/2" title="PhRMA code tightens limits on gift giving. : An article from: Skin &#038; Allergy News" rel="nofollow"><b>PhRMA code tightens limits on gift giving. : An article from: Skin &#038; Allergy News</b></a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmaceuticalclinicaltrials.com/phrma-code-tightens-limits-on-gift-giving-an-article-from-skin-allergy-news-8/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drug Regulatory Affairs &#8211; Careers &amp; Prospects &#8211; Pharmaceutical Industry</title>
		<link>http://www.pharmaceuticalclinicaltrials.com/drug-regulatory-affairs-careers-prospects-pharmaceutical-industry-38/</link>
		<comments>http://www.pharmaceuticalclinicaltrials.com/drug-regulatory-affairs-careers-prospects-pharmaceutical-industry-38/#comments</comments>
		<pubDate>Sun, 06 Dec 2009 17:07:51 +0000</pubDate>
		<dc:creator>Pharma Tech</dc:creator>
				<category><![CDATA[Trials]]></category>
		<category><![CDATA[10 Years]]></category>
		<category><![CDATA[Affairs]]></category>
		<category><![CDATA[Amp]]></category>
		<category><![CDATA[Cagr]]></category>
		<category><![CDATA[Careers]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Health Care Products]]></category>
		<category><![CDATA[Health Products]]></category>
		<category><![CDATA[Heart]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indian Pharmaceutical Industry]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[Legislation]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Prime Responsibilities]]></category>
		<category><![CDATA[Profession]]></category>
		<category><![CDATA[Prospects]]></category>
		<category><![CDATA[Ra]]></category>
		<category><![CDATA[Registration Documents]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Regulatory Affairs]]></category>
		<category><![CDATA[Regulatory Agencies]]></category>
		<category><![CDATA[Selling Drugs]]></category>
		<category><![CDATA[Time And Money]]></category>

		<guid isPermaLink="false">http://www.pharmaceuticalclinicaltrials.com/drug-regulatory-affairs-careers-prospects-pharmaceutical-industry-38/</guid>
		<description><![CDATA[
 
 What is Regulatory Affairs???? :- 
Regulatory Affairs (RA) is an upcoming profession within the biomedical / health products sector. RA profession at its heart is all about Collecting, Analyzing and Communicating the Risks and Benefits of health care products to regulatory agencies and public all over the world.
In an organization their prime responsibilities involves [...]]]></description>
			<content:encoded><![CDATA[</p>
<p> </p>
<p> <strong>What is Regulatory Affairs???? :- </strong>
<p>Regulatory Affairs (RA) is an upcoming profession within the biomedical / health products sector. RA profession at its heart is all about Collecting, Analyzing and Communicating the Risks and Benefits of health care products to regulatory agencies and public all over the world.</p>
<p>In an organization their prime responsibilities involves preparation and presentation of registration documents to regulatory agencies and carry out all following discussion to obtain and maintain marketing authorization (MA) for the products concerned.</p>
<p>They need to keep a track on ever changing legislation in all countries where the companies is looking to market their product.</p>
<p>RA profession is broader than registration of products, they advise companies both strategically and technically at the highest level. Their role begins right from development of a product to making, marketing and post marketing. Their advice at all stages both in terms of legal and technical requirements and restrains help companies save a lot of time and money in developing the product and marketing the same.</p>
<p>They have a major contribution in company’s success both Commercially and Scientifically.</p>
<p><strong>Careers in Regulatory Affairs:- </strong></p>
<p>Pharma is a highly regulated industry the world over and professionals, who can manage regulatory affairs, are in high demand.</p>
<p>Selling drugs is not like selling anything else, when we sell drugs we need to be confident that</p>
<p> They do what they claim to do  They have been through a tough testing process to get from the lab to the market  The side effects are well documented
<p> </p>
<p>This is where regulatory affairs come in.</p>
<p><strong>“Regulatory Affairs Professional is the key link to distributing your drugs to world region.”</strong></p>
<p>The Indian Pharmaceutical industry is one of the fastest growing industry in India, with a CAGR of over 13 % in last 5 years and it is expected to grow at a higher rate in coming 10 years. It is valued at $ 8.0 billion approximately and ranks 4th in terms of volume and 13th in terms of value globally.</p>
<p>With such a high growth rate and rapid globalization there is a substantial need for highly trained professionals ready to perform the work required within this specialized industrial sector who will keep updates with regulatory law, policies and procedures for one or more product lines as well as maintain an understanding of the scientific and technical background of new products.</p>
<p>The increasing graph of the global companies’ setup in India demands the trained and skilled professional on a <strong>Handsome Salary</strong>, looking back for past few years rise in salary is multiplying.</p>
<p>There is a widening gap of rising demand and too few skilled human resource, this has seen a 50 % zoom on average in salaries for skilled manpower specifically in CRO sector alone.  On an average there has been over 30% rises in salaries in Pharmaceutical Sector.</p>
<p>Research &amp; Development activity in the Pharma sector is seeing a rapid growth and this growth is only poised to increase the need for skilled manpower and higher pay scale to retain the skilled.</p>
<p><strong>What you will need to become a RA professional :- </strong></p>
<p> A good background knowledge of the pharmaceuticals and medical environment  A meticulous approach to work  Attention to detail.  Academic Qualification in Regulatory Affairs
<p>You can expect to work in a multidisciplinary workplace where scientists and medics will come from very different backgrounds. Excellent written and verbal communication skills are a must as is the ability to work effectively under pressure.</p>
<p><strong>Global Institute of Regulatory Affairs (GIRA)</strong></p>
<p>GIRA has developed a Post Graduate Diploma (Sunday batches) and Advanced P.G. Diploma in RA (Full Time) which will surely help the professionals as the program address regulatory Affairs within each category of regulatory agencies of various country, Drugs and Medical devices.</p>
<p>This Program will be a complement to those who carrying Science, Pharmacy and Health related degrees, there are many rewarding career opportunities with regulatory affairs for individuals with a variety of backgrounds.</p>
<p>The courses has been developed, under the guidance of Industry and Government Experts, to provide broad regulatory foundations, exposure to the practical, real-world applications of the regulations, and an appreciation of the important roles that regulatory affairs professionals play in the bioscience industry.</p>
<p>Courses are taught by experienced regulatory professionals currently working in device, diagnostic, pharmaceutical and biologic sectors. Instructors bring the regulations to life and infuse their courses with relevant examples and hands-on exercises designed to prepare students for rewarding careers in regulatory affairs.</p>
<p>GIRA is a Division of “Perfect Pharmaceutical Consultants Pvt Ltd” – providing intelligent regulatory solutions since last 20 years</p>
<p>Please contact GIRA for  “FREE Counseling &amp; Course Prospectus”</p>
<p>To know more on RA and its Career visit White Paper section on</p>
<p>Global Institute of Regulatory Affairs</p>
<p><a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="http://www.regulatoryinstitute.com/">www.regulatoryinstitute.com</a></p>
<p> </p>
<p> </p>
<div style="margin:5px;padding:5px;border:1px solid #c1c1c1;font-size: 10px;">
<div class="text">
<p>
Sumit Gupta</p>
<p>Global Institute of Regulatory Affairs &#8211; <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="http://www.regulatoryinstitute.com" target="_blank">www.regulatoryinstitute.com</a></p>
<p>Email ? <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="mailto:info@regulatoryinstitute.com">info@regulatoryinstitute.com</a> / <a rel="nofollow" onclick="javascript:pageTracker._trackPageview('/outgoing/article_exit_link');" href="mailto:girapune@gmail.com">girapune@gmail.com</a></p>
</div>
</div>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmaceuticalclinicaltrials.com/drug-regulatory-affairs-careers-prospects-pharmaceutical-industry-38/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
	</channel>
</rss>
